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Introduction: The diagnostic yield of flexible bronchoscopy for
peripheral pulmonary lesions is variable and often limited. Endo-
bronchial ultrasonography (EBUS) has been reported to help local-
ize a bronchoscopic occult pulmonary lesion and thereby improve
the diagnostic yield of transbronchial biopsy (TBB).
Methods: We evaluated the yield of EBUS-guided TBB in 50
consecutive patients with a bronchoscopic occult pulmonary lesion.
Results: The mean diameter of the lesions was 36.6 mm (SD 19.7
mm). We could visualize 74% of the bronchoscopic occult lesions
with EBUS, and in these patients, a histologic diagnosis on TBB was
obtained in 84%. However, the diagnostic yield was very poor for
lesions 20 mm.
Conclusion: EBUS-guided TBB is effective for localizing and
diagnosing bronchoscopic occult pulmonary masses 20 mm, but
its yield remains unsatisfactory for lesions 20 mm.
Key Words: Bronchoscopy, Endobronchial ultrasonography, Pul-
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(J Thorac Oncol. 2007;2: 121–124)
Flexible bronchoscopy has a variable and often poor diag-nostic yield for pulmonary lesions in cases of a normal
endobronchial examination on bronchoscopy. The sensitivity
of bronchoscopy for detecting malignancy in a solitary pul-
monary nodule depends on the size of the nodule, the prox-
imity to the bronchial tree, and the prevalence of cancer in the
study population. For nodules that are 20 to 30 mm in
diameter, the sensitivity is 40% to 60%.1 The diagnostic yield
is mostly achieved with the auxiliary use of radiographic
fluoroscopic guidance, but lesions 20 mm in diameter
remain difficult to detect, with a diagnostic yield of30%. In
the absence of radiographic fluoroscopic guidance, it can
often be difficult to identify the correct distance and bronchial
access to a peripheral pulmonary lesion 20 mm.
Endobronchial ultrasonography (EBUS) using a mini-
probe has been reported to be useful in confirming the
accurate bronchial route and obtaining a histologic diagnosis
of peripheral pulmonary lesions.2,3
In this study, the diagnostic efficacy of EBUS-guided
transbronchial biopsy (TBB), in the absence of radiographic
fluoroscopic guidance, was evaluated in a series of consecu-
tive patients with a pulmonary mass and normal broncho-
scopic inspection.
PATIENTS AND METHODS
From January 1 to May 31, 2005, we prospectively
studied the use of EBUS-guided TBBs in patients referred to
the endoscopy unit with a pulmonary nodule or solid mass.
During this period, EBUS was added in 50 consecutive
patients having normal endoluminal findings on routine di-
agnostic bronchoscopy. A pulmonary nodule or solid mass
was defined as a lesion surrounded by pulmonary paren-
chyma on computed tomography (CT). Spiral chest CT was
reviewed before the procedure, and the largest diameter of the
lesion was measured on the soft-tissue windows. Patients
with a spiral CT showing a pulmonary infiltrate (with the
presence of an air bronchogram in the lesion and thus a high
likelihood of a benign infectious lesion) or a subpleural lesion
lying entirely within 10 mm from the pleura (as an EBUS
miniprobe performs only radial scanning at 10 mm from its
distal tip) were excluded from this study. After informed
consent, bronchoscopy using local anesthesia was performed
with a flexible bronchoscope (BF-1T160; Olympus). All
patients received oxygen 2 liters/min via a nasal cannula, and
blood oxygenation was monitored with continuous pulse
oximetry. Fluoroscopy was not used during the procedure
because it is not available in our endoscopy unit.
The EBUS system (processor EU-M20 and driving unit
MH-240; Olympus), equipped with a 20-MHz mechanical
radial miniprobe (UM-BS20-26R; Olympus) with a balloon
sheath (MAJ-643R; Olympus), has been used by one staff
member of the respiratory endoscopy unit. After localization
of the lesion, the bronchoscope was kept in place at the
nearest visible subsegmental carina, and the miniprobe was
removed while measuring the distance to the lesion. We did
not use a catheter sheath because it renders the procedure
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technically less comfortable and limits the size of the biopsy
forceps used. Thereafter, a biopsy forceps (FB-20C-1; Olym-
pus) was introduced into the subsegmental bronchus for a
distance as measured before, and four or more biopsy spec-
imens were taken and fixed in Bouin’s solution for histologic
analysis. No biopsy specimens were taken in those patients in
whom EBUS did not image the lesion.
At the end of the procedure, wedged bronchial lavage
was performed in all patients in the suspected subsegmental
bronchus using 50 ml of saline. This material was stored in
Cytorich Red solution for cytologic analysis.
RESULTS
A total of 50 patients (34 males and 16 females) with an
average age of 69 years were examined. The mean diameter
of the lesions on CT was 36.6 19.7 mm (range, 8–90 mm).
The location of the lesions was variously distributed: 14 in
the right upper lobe, five in the right middle lobe, eight in the
right lower lobe, 15 in the left upper lobe, and eight in the left
lower lobe.
In 34 patients, a pathologic (histology  cytology)
diagnosis could be established: primary lung cancer in 28
patients (adenocarcinoma, n  7; squamous cell carcinoma,
n  5; large cell carcinoma, n  13; and small cell lung
carcinoma, n  3). A benign lesion could be documented in
six patients (bronchiolitis obliterans in two patients and
posttransplantation lymphoma, mucor mycosis infection, an-
thracosilicosis that proved to be stable at follow-up, and
Mycobacterium tuberculosis infection in one patient each)
(Table 1). The bronchoscopic occult lesion could be visual-
ized with EBUS in 37 of 50 patients (74%), and a histologic
diagnosis could be established in 31 of these 37 (84%).
In 16 patients, no diagnosis was obtained during bron-
choscopy (Table 1). These undiagnosed lesions were homo-
geneously spread: 34% (10 of 34 lesions) in the upper lobe
segments, 29% (six of 21 lesions) in the lower/middle lobe
segments. In 13 patients, the lesion could not be found with
EBUS, although access was considered feasible based on the
CT scan, leading to 11 nondiagnostic bronchoscopies, as
additional cytologic examination of the lavage fluid was
diagnostic in two of these (non-small cell lung cancer and
Mycobacterium tuberculosis one each). A bronchoscopic di-
agnosis was also lacking in five patients in whom the lesion
was visible on EBUS. In two of these, with visualization on a
tangential EBUS image, the diagnosis ultimately proved to be
non-small cell lung cancer (B2r, 37mm) and metastasis of a
colorectal carcinoma (B3r, 11 mm) in one each. Three patients,
with visualization on circular EBUS, ultimately proved to have
a lymphoma (B5l, 43 mm) and two had an unknown but stable
lesion at follow-up (B1l, 23 mm and B1r, 40 mm).
Moderate bleeding requiring only bronchoscopic hemo-
stasis was noted in one patient. No significant adverse effects
(pneumothorax, respiratory distress, or urgent surgery) occurred.
An overall pathologic diagnostic yield of 68% was
obtained (Table 2). For lesions 20 mm in the greatest
diameter, the pathologic diagnostic yield decreased to 18%,
whereas 82% was reached for lesions20 mm. In the overall
group, the average diameter of the diagnosed lesions (41 mm;
range, 15–90) was significantly higher than the average
diameter of the undiagnosed lesions (27 mm; range, 8–87,
p  0.013). However, when considering only lesions 20
mm, there was no difference between the average diameter of
the diagnosed lesions (42 mm; range, 20–90) and the average
diameter of the undiagnosed lesions (43 mm; range, 23–87,
p  0.977). Because size does not discriminate between
diagnosed and undiagnosed lesions for the subgroup 20
mm, we hypothesized that other factors did, such as a tan-
gential visualization (e.g., hematogenous metastasis) or an
inaccessible target bronchus (e.g., occlusion of the bronchus
leading toward the lesion).
DISCUSSION
EBUS can guide TBB by revealing the optimal bron-
chial access and measure the distance to a pulmonary lesion.
The reflection of adjacent zones of normal aerated lung tissue
generally defines a peripheral lesion as a clear hypoechoic
texture on EBUS (Figure 1). Most of the published studies
(Table 3) used radiographic fluoroscopy, with radiation ex-
posure for both the patient and medical staff.4–6 Only Herth
et al.3 reported on the feasibility of EBUS-guided TBB
without the use of fluoroscopy in lesions 20 mm.
In the present study, the use of EBUS led to visualiza-
tion of 90% of the bronchoscopic occult lesions20 mm and
to a pathologic diagnostic yield of 82% (Table 2). This result
is in line with the study by Herth et al., including only
peripheral pulmonary lesions 20 mm and reporting a diag-
nostic yield of 87% for EBUS-guided TBB without the need
for radiographic equipment or radiation exposure (Table 3).
For lesions20 mm, our yield of EBUS-guided detection
and pathologic diagnosis decreased to 18%. In contrast, Japa-






No. of patients 50 11 39
EBUS-V, no. (%) 37/50 (74) 2/11 (18) 35/39 (90)
EBUS-TBB, no. (%) 31/37 (84) 1/2 (50) 30/35 (86)
Pathologic diagnosis, n (%) 34/50 (68) 2/11 (18) 32/39 (82)
EBUS-V, visible on endobronchial ultrasonography; EBUS-TBB, positive endo-
bronchial ultrasonography when visible on endobronchial ultrasonography.
TABLE 1. Description of the Pathologic Result in Relation
to EBUS Characteristics
All <20 mm >20 mm
EBUS visible (n  37)
Histology diagnosis 31 1 30
No diagnosis 5 1 4
Cytology diagnosis 1 0 1
EBUS invisible (n  13)
No diagnosis 11 8 3
Cytology diagnosis 2 1 1
EBUS, endobronchial ultrasonography.
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nese groups have reported diagnostic yields of 53% and 72%,
respectively, for lesions20mm using EBUS-guided TBBwith
a catheter sheath and under radiographic fluoroscopy.5,6 More
recently, one of these Japanese groups performed EBUS-guided
TBB using virtual bronchoscopic navigation and detected 67%
of lesions 20 mm on EBUS, resulting in a diagnostic yield of
44%.7 A higher diagnostic yield of 63% has been reported for
CT-guided TBB, but this method is less desirable because of
excessive radiation exposure from CT and lengthy occupation of
the CT room.8 CT-guided percutaneous transthoracic fine-nee-
dle aspiration biopsy may be considered in very small, easily
accessible peripheral lesions. Its sensitivity for detecting malig-
nancy in lesions 20 mm in diameter has been reported to be
60%.9,10 Electromagnetic navigation in bronchoscopy is a
novel method of assessing the localization of peripheral pulmo-
nary lesions and may be of further help to improve the diagnos-
tic yield of bronchoscopy in very small peripheral pulmonary
nodules.11,12
In summary, in the daily experience of clinicians,
EBUS-guided TBB is effective for detecting and diagnosing
peripheral pulmonary nodules or masses 20 mm, but its yield
remains unsatisfactory for lesions 20 mm. Based on these
findings, increased use of the technique, both in standard pul-
monary practice and in prospective multicenter studies, is war-
ranted. The advantage of using an EBUS miniprobe in the
detection and diagnosis of bronchoscopic occult pulmonary
lesions 20 mm is that use of radiographic fluoroscopy can be
abandoned. Careful positioning and measurement of the distance
to the lesion remain essential. Studies with new navigation
techniques such as virtual bronchoscopy and electromagnetic
navigation may improve the diagnostic yield of lesions 20
mm, but EBUS will be useful as well in these cases to confirm
accurate insertion into the lesion.
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